Insulin receptor variant forms and Type 2 diabetes mellitus

Pharmacogenomics

Volumn 1, Issue 1, 2000, Pages 49-61

  Sesti, Giorgio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Genetics of Type 2 diabetes; Hybrid receptor; IGF I receptor; Insulin receptor isoforms; Insulin resistance; Type 2 diabetes

Indexed keywords

INSULIN RECEPTOR;

CHEMISTRY; GENETICS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

DIABETES MELLITUS, TYPE 2; HUMANS; RECEPTOR, INSULIN;

EID: 0034139522     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.1.1.49     Document Type: Review

References (67)

1. DE FRONZO RA: Pathogenesis of Type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev. (1997) 5:177-269.
2. WEYER C, BOGARDUS C, MOTT DM, PRATLEY RE: The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of Type 2 diabetes mellitus. J. Clin. Invest. (1999) 104:787-794. Longitudinal study on a population at high risk for diabetes.
3. RICH SS: Mapping genes in diabetes: genetic epidemiological perspective. Diabetes (1990) 39:1315-1319.
4. TAYLOR SI, CAMA A, ACCILI D et al.: Mutations in the insulin receptor gene. Endocrine Rev. (1992) 13:566-595. Exhaustive review on insulin receptor gene mutations.
5. FROGUEL P, VAXILLAIRE M, SUN F et al: Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature (1992) 356:162-161 Identification of gene mutation causing MODY.
6. YAMAGATA K, ODA N, KAISAKI PJ et al.: Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young. Nature (1996) 384:455-458. Identification of gene mutation causing MODY.
7. YAMAGATA K, FURUTA H, ODA N et al.: Mutations in the hepatocyte nuclear factor-4 alpha gene in maturity-onset diabetes of the young. Nature (1996) 384:458-460. Identification of gene mutation causing MODY.
8. STOFFERS DA, ZINKIN NT, STANOJEVIC V, CLARKE WL, HABENER JF: Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nature Genet. (1997) 15:106-110. Identification of gene mutation causing agenesis of pancreas.
9. ROTHENBERG PL, WILLISON LD, SIMON J, WOLF BA: Glucose-induced insulin receptor tyrosinc phosphorylation in insulin-secreting beta-cells. Diabetes (1995) 44:802-609.
10. 972→Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic β-cells. J. Clin. Invest. (1999) 104:357-364. Identification of gene defect in insulin signaling causing β-cell dysfunction.
11. KULKARNI RH, WINNAY JN, DANIELS M et al. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured β-cell lines. J. Clin. Invest. (1999) 104:R69-R75.
12. KULKARNI RN, BRUNING JC, WINNAY JN, POSTIC C, MAGNUSON MA, KAHN CR: Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in Type 2 diabetes. Cell (1999) 96:329-339. Animal model of Type 2 diabetes.
13. WHITE MF: The insulin signalling system and the IRS proteins. Diabetologia (1997) 40:S2-S17.
14. ULLRICH A, BELL JR, CHEN EY et al: Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature (1985) 313:756-761. Cloning of the human insulin receptor.
15. EBINA Y, ELLIS L, JARNAGIN K et al.: The structural basis for hormone-activated transmembrane signalling. Cell (1985) 40:747-758. Cloning of the human insulin receptor.
16. SEINO S, SEINO M, NISHI S, BELL GI: Structure of the human insulin receptor gene and characterization of its promoter. Proc. Natl. Acad. Sci. USA (1989) 86:114-118.
17. KRISTENSEN C, WIBERG FC, SCHAFFER L, ANDERSEN AS: Expression and characterization of a 70-kDa fragment of the insulin receptor that binds insulin. J. Biol. Chem. (1998) 273:17780-17786.
18. SESTI G, TULLIO AN, D'ALFONSO R et al.: Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein. Acta Diabetologica (1994) 31:59-65
19. MOSTHAF L, GRAKO D, DULL TJ, COUSSENS L, ULLRICH A, MCCLAIN DA: Functionally distinct insulin receptors generated by tissue-specific alternative splicing. EMBO J. (1990) 9:2-409-2413. Characterisation of functional differences between the two insulin receptor forms.
20. VOGT B, CARRASCOSA JM, ERMEL B, ULLRICH A, HARING HU: The two isotypes of the human insulin receptor (HIR-A and HIR-B) follow different internalization kinetics. Biochem. Biophys. Res. Comm. (1991) 177:1013-1018.
21. YAMAGUCHI Y, FLIER JS, YOKOTA A, BENECKE H, BACKER JM, MOLLER DE: Functional properties of two naturally occurring isoforms of the human insulin receptor in Chinese hamster ovary cells. Endocrinology (1991) 129:2058-2066.
22. MCCLAIN DA: Different ligand affinities of the two human insulin receptor splice variants arc reflected in parallel changes in sensitivity for insulin action. Mol. Endocrinol. (1991) 5:734-739.
23. SESTI G, MARINI MA, MONTEMURRO A et al.: Evidence that two naturally occurring human insulin receptor α-subunit variants arc immunologically distinct. Diabetes (1992) 41:6-11. Immunological differences between the two insulin receptor forms.
24. YAMAGUCHI Y, FLIER JS, BENECKE H, RANSIL BJ, MOLLER DE: Ligand-binding properties of the two isoforms of the human insulin receptor. Endocrinology (1993) 132:1132-1138.
25. SESTI G, TULLIO AN, MARINI MA et al.: Role of the exon 11 of the insulin receptor gene on insulin binding identified by anti-peptide antibodies. Mol. Cell Endocrinol. (1994) 101:121-127.
26. NORGREN S, ZIERATH J, WEDELL A, WALLEBERG-HENRIKSSON H, LUTHMAN H: Regulation of human insulin receptor RNA splicing in vivo. Proc. Natl. Acad. Sci. USA (1994) 91:1465-1469.
27. NORGREN S, SHENG LI L, LUTHMAN H: Regulation of human insulin receptor RNA splicing in HepG2 cells: effects of glucocorticoid and low glucose concentration. Biochem. Biophys. Res. Comm. (1994) 199:277-284.
28. SESTI G, D'ALFONSO R, VARGAS PUNTI MD et al.: Peptide-based radioimmunoassay for the two isoforms of the human insulin receptor. Diabetologia (1995) 38:445-453. Quantitation of the two insulin receptor protein forms in Type 2 diabetes.
29. ULLRICH A, GRAY A, TAM AW et al.: Insulin-like growth factor 1 receptor primary structure: comparision with insulin receptor suggests structural determinants that define functional specificity. EMBO J. (1986) 5:2503-2512. Cloning of the IGF-I receptor.
30. SOOS MA, SIDDLE K: Immunological relationships between receptors for insulin and insulin-like growth factor-I. Biochem. J. (1989) 263:553-563.
31. KASUYA J, PAZ B, MADDUX BA, GOLDFINE ID, HEFTA SA, FUJITA-YAMAGUCHI Y: Characterization of human placental insulin-like growth factor-I/insulin hybrid receptors by protein microsequencing and purification. Biochemistry (1993) 32:13531-13536.
32. SOOS MA, WHITTAKER J, LAMMERS R, ULLRICH A, SIDDLE K: Receptor for insulin and insulin-life growth factor-I can form hybrid dimers. Biochem. J. (1990) 270:383-390.
33. TREADWAY JL, MORRISON B, GOLDFINE ID, PESSIN JE: Assembly of insulin/insulin-like growth factor-I hybrid receptors in vitro. J. Biol. Chem. (1989) 264:21450-21453.
34. SOOS MA, FIELD CE, SIDDLE K: Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity. Biochem. J. (1993) 290:419-426. Functional characterisation of insulin/insulin-like growth factor-I hybrid receptors.
35. LANGLOIS WJ, SASAOKA T, YIP CC, OLEFSKY JM: Functional characterization of hybrid receptors composed of a truncated insulin receptor and wild Type insulin-like growth factor 1 or insulin receptor. Endocrinology (1995) 136:1978-1986. Functional characterisation of insulin/insulin-like growth factor-I hybrid receptors.
36. SEELY BL, REICHART DR, TAKATA Y, YIP CC, OLEFSKY JM: A functional assessment of insulin/insulin-like Growth Factor-I hybrid receptors. Endocrinology (1995) 136:1635-1641.
37. FEDERICI M, PORZIO O, ZUCARO L et al.: Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues. Mol. Cell. Endocrinol. (1997) 129:121-126.
38. BAILYES EM, NAVE BT, SOOS MA, ORR SR, HAYWARD AC, SIDDLE K: Insulin receptor/IGF-I receptor hybrids are widely distributed in mammalian tissues: quantification of individual receptor species by selective immunoprecipitation and immunoblotting. Biochem. J. (1997) 327:209-215.
39. FEDERICI M, LAURO D, D'ADAMO M et al.: Expression of insulin/IGF-I hybrid receptors is increased in skeletal muscle of patients with chronic primary hyperinsulinemia. Diabetes (1998) 47:87-92.
40. FEDERICI M, PORZIO O, LAURO D et al.: Increased abundance of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of obese subjects is correlated with in vivo insulin sensitivity. J. Clin. Endocrinol. Metab. (1998) 83:2911-2915.
41. FEDERICI M, GIACCARI A, HRIBAL ML et al.: Evidences for Glucose/Hexosamine In vivo Regulation of Insulin/IGF-I Hybrid Receptors Assembly. Diabetes (1999) 48:2277-2285.
42. MODAN-MOSES D, JANICOT M, MCLENITHAN JC, LANE MD, CASELLA SJ: Expression and function of insulin/insulin-like growth factor I hybrid receptors during differentiation of 3T3-L1 preadipocytes. Blochem. J. (1998) 333:825-831.
43. MOLLER DE, YOKOTA A, FLIER JS: Normal insulin receptor cDNA sequence in Pima Indians with NIDDM. Diabetes (1989) 38:1496-1500.
44. D'ALFONSO R, FUSCO A, NAPOLITANO ML et al: Unconfirmed polymorphisms in the human insulin receptor gene. Exp. Clin. Endocrinol. (1993) 101 (Suppl. 2):52-53.
45. O'RAHILLY J, CHOI WH, PATEL P, TURNER RC, FLIER JS, MOLLER DE: Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformational polymorphisms. Diabetes (1991) 40:777-782.
46. STRACK V, BOSSENMAIER B, STOYANOV B, MUSHACK J, HARING HU: A 973 valine to methionine mutation of the human insulin receptor: interaction with insulin-receptor substrate-1 and She in HEK 293 cells. Diabetologia (1997) 40:1135-1140.
47. MOSTHAF L, VOGT B, HARING HU, ULLRICH A: Altered expression of insulin receptor types A and B in the skeletal muscle of non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA (1991) 88:4728-4730.
48. MOSTHAF L, ERIKSSON J, HARING HU, GROOP L, WIDEN E, ULLRICH A: Insulin receptor isotypes expression correlates with risk of non-insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA (1993) 90:2633-2635.
49. NORGREN S, ZIERATH J, GALUSKA D, WALLEBERG-HENRIKSSON H, LUTHMAN H: Differences in the ratio of RNA encoding two isoforms of the insulin receptor between control and NIDDM patients. Diabetes (1993) 42:675-681.
50. BENECKE H, FLIER JS, MOLLER DE: Alternatively spliced variants of the human insulin receptor protein. J. Clin. Invest. (1992) 89:2066-2070.
51. ANDERSON CM, HENRY RR, KNUDSON PE, OLESKY JM, WEBSTER NJG: Relative expression of insulin receptor isoforms does not differ in lean, obese, and noninsulin-dependent diabetes mellitus subjects. J. Clin. Endocrinol. Metab. (1993) 72:1380-1383.
52. HANSEN T, BJORBAEK C, VESTERGAARD H, GRONSKOV K, BAK JF, PEDERSEN O: Expression of insulin receptor spliced variants and their functional correlates in muscle from patients with non-insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. (1993) 77:1500-1505.
53. SESTI G, MARINI MA, TULLIO AN et al.: Altered expression of the two naturally occurring human insulin receptor variants in isolated adipocytes of non-insulin-dependent diabetes mellitus patients. Biochem. Biophys. Res. Comm. (1991) 181:1419-1424.
54. KELLERER M, SESTI G, SEFFER E et al: Altered pattern of insulin receptor isotypes in skeletal muscle membranes of Type II (non-insulin-dependent) diabetic subjects. Diabetologia (1993) 36:628-632.
55. SBRACCIA P, D'ADAMO M, LEONETTI F et al.: Chronic primart hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of patients with insulinoma. Diabetoligia (1993) 39:220-225.
56. FEDERICI M, ZUCAKO L, PORZIO O et al.: Increased expression of insulin/insulin-like growth factor-I hybrid receptors in skeletal muscle of non-insulin-dependent diabetes mellitus subjects. J. Clin. Invest. (1996) 98:2887-2893. Evaluation of insulin/insulin-like growth factor-I hybrid receptors in Type 2 diabetes.
57. FEDERICI M, PORZIO O, ZUCARO L et al.: Increased abundance of insulin/IGF-I hybrid receptors in adipose tissue from NIDDM patients. Mol. Cell. Endocrinol. (1997) 135:41-47.
58. VALENSISE H, LIU YY, FEDERICI M et al.: Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin resistant women with gestational hypertension. Diabetologia (1996) 39:952-960.
59. CAMA A, PATTERSON A, KADOWAKI T et al.: Cloning of insulin receptor cDNA from an insulin resistant Pima Indian. J. Clin. Endocrinol. Metab. (1990) 70:1155-1161.
60. KUSARI J, VERMA US, BUSE JB, HENRY RR, OLEFSKY JM: Analysis of the gene sequences of the insulin receptor and insulin-sensitive glucose transporter (GLUT-4) in patients with common-type non-insulin-dependent diabetes mellitus. J Clin. Invest. (1991) 88:1323-1330.
61. O'RAHILLY J, KROOK, MORGAN R, REES A, FLIER JS, MOLLER DE: Insulin receptor and insulin-responsive glucose transportr (GLUT-4) mutations and polymorphisms in a Welsh Type 2 (non-insulin-dependent) diabetic population. Diabetologia (1992) 35:486-489.
62. HANSEN L, HANSEN T, CLAUSEN JO et al.: The val985met insulin-receptor variant in the Danish Caucasian population: lack of associations with non-insulin-dependent diabetes mellitus or insulin resistance. Am. J. Hum. Genet. (.1997) 60:1532-1535.
63. 'T HART LM, STOLK RP, HEINE RJ, GROBBEE DE, VAN DER DOES FE, MAASSEN JA: Association of the insulin-receptor variant Met-985 with hyperglycemia and non-insulin-dependent diabetes mellitus in the Netherlands: a population-based study. Am. J. Hum. Genet. (1996) 59:1119-1125.
64. 'T HART LM, STOLK RP, DEKKER JM et al.: Prevalence of variants in candidate genes for Type 2 diabetes mellitus in the Netherlands: the Rotterdam study and the Hoorn study. J Clin. Endocrinol. Metab. (1999) 84:1002-1006.
65. COCOZZA S, PORCELLINI A, RICCARDI G et al.: NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene. Diabetes (1992) 41:521-526.
66. PETRUZZIELLO A, FORMISANO P, MIELE C et al.: Defective insulin action in fibroblasts from noninsulin-dependent diabetes mellitus patients with Gln 1152 insulin receptor mutation. J. Clin. Endocrinol. Metab. (1993) 77:409-412.
67. KAN M, KANAI F, IIDA M et al.: Frequency of mutations of insulin receptor gene in Japanese patients with NIDDM. Diabetes (1995) 44:1081-1086.